Anti-CD22 [hL22 (Epratuzumab)] | Absolute Antibody Ab00728-10.0 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Absolute Antibody

product type :

antibody

product name :

Anti-CD22 [hL22 (Epratuzumab)]

catalog :

Ab00728-10.0

quantity :

200 μg

clonality :

monoclonal

host :

human

conjugate :

nonconjugated

clone name :

hL22 (Epratuzumab)

The same clone is also sold as:

MyBioSource: MBS488272

reactivity :

human

application :

neutralization, immunoprecipitation, flow cytometry

product information

Product Name :

Anti-CD22 [hL22 (Epratuzumab)]

Catalog Number :

Ab00728-10.0

Target :

CD22

Antibody Species :

Human

Isotype :

IgG1

LCFormat :

kappa

Target Synonyms :

Leu14; B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BL-CAM; Sialic acid-binding Ig-like lectin 2; Siglec-2; T-cell surface antigen Leu-14

Display Amount :

200 μg

PriceGBP :

285

PriceEUR :

315

Product Type :

Primary Antibody

Clonality :

Monoclonal

ApplicationCodesClone :

Blocking; IP; FC

Immunogen :

This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5–10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010).

MarketingCategories :

oncology; autoimmunity; biosimilar

Available Custom Conjugation Options :

AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

UniprotAccessionNo :

P20273

Product Description :

This is a recombinant monoclonal antibody.